Khaya grandifoliola active fraction as a source of therapeutic compounds for Alzheimer’s disease treatment: In silico validation of identified compounds-Reference-Cited by-同舟云学术

Khaya grandifoliola active fraction as a source of therapeutic compounds for Alzheimer’s disease treatment: In silico validation of identified compounds

Published:2022-07-04 Issue:1 Volume:10 Page:
ISSN:2193-9616
Container-title:In Silico Pharmacology
language:en
Short-container-title:In Silico Pharmacol.

Author:

Owona Brice Ayissi,Njayou Frederic N.,Mkounga Pierre,Moundipa Paul F.

Funder

DAAD

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40203-022-00126-0.pdf

Reference41 articles.

1. Abdipranoto-Cowley A, Jin SP, Croucher D, Daniel J, Henshall S, Galbraith S, Mervin K, Vissel B (2009) Activin A is essential for neurogenesis following neurodegeneration. Stem Cells 27:1330–1346. https://doi.org/10.1002/stem.80

2. Akiyama H, Arai T, Kondo H, Tanno E, Haga C, Ikeda K (2000) Cell mediators of inflammation in the Alzheimer disease brain. Alzheimer Dis Assoc Disord 14(Suppl 1):S47–S53. https://doi.org/10.1097/00002093-200000001-00008

3. Aktan F (2004) iNOS-mediated nitric oxide production and its regulation. Life Sci 75:639–653. https://doi.org/10.1016/j.lfs.2003.10.042

4. Aldskogius H (2000) Microglia–new target cells for neurological therapy. Lakartidningen 97:3358–3362

5. Bickii J, Njifutie N, Ayafor Foyere J, Basco LK, Ringwald P (2000) In vitro antimalarial activity of limonoids from Khaya grandifoliola C.D.C. (Meliaceae). J Ethnopharmacol. https://doi.org/10.1016/S0378-8741(99)00117-8

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biflavonoid Methylchamaejasmin and Khaya grandifoliola Extract Inhibit NLRP3 Inflammasome in THP-1 Cell Model of Neuroinflammation;Molecular Neurobiology;2024-07-16